Materiality

Materiality(material issues)

Mochida Pharmaceutical Group identified material matters which the Group should address as a priority for the sustainable improvement of corporate value as materiality (material issues).
By focusing on our materiality, we will contribute to the realization of a sustainable society.

Identifying Material Issues

Through an assessment focusing on the two aspects of "importance to society" and "importance to the Group," we identified "development of human resources," "compliance," "creation of unique products to meet needs," "stable supply of high quality pharmaceuticals" and "proper provision of valuable information" as material issues.

Process for Identifying Material Issues

The Group identified material issues through the process shown in the figure on the right, with reference to various principles and guidelines. We will review our material issues as appropriate, with adapting flexibly to future changes in society.

[Step1] Identifying issues

Identify a wide range of issues which are potential material issues, taking various principles and guidelines (SDGs, GRI Index, ISO26000, etc.) into consideration.

[Step2] Organizing potential material issues

Map the identified issues on two axes: importance to society and importance to the Group, and narrow down the most important matters.

[Step3] Identifying material issues

Identify the Group's material issues through internal discussion of the issues organized according to the above criteria, primarily at meetings of the Board of Directors and Sustainability Committee.

The Five Material Issues

Among the Group's five material issues, the Group will work on "development of human resources" and "compliance" as material issues underpinning the management foundations and on "creation of unique products to meet needs," "stable supply of high quality pharmaceuticals" and "proper provision of valuable information" as material issues in relation to our businesses.

Material issues underpinning the management foundations

• We believe that a major driver underpinning corporate value creation is "human resources" and we will, therefore, strive to create company and workplaces where every employee can demonstrate their full potential and grow
• We are committed to promoting "compliance," which is an absolute condition for corporate survival

[Material issues underpinning the management foundations]

Material issues in relation to our businesses

• We will continue working on the "creation of unique products to meet needs," perceiving increasingly diverse medical and healthcare needs as a business opportunity and adapting to changes of the business environment
• Through the "stable supply of high quality pharmaceuticals" and "proper provision of valuable information," we will contribute to human health and well-being and seek enhancement in our corporate value

[Material issues in relation to our businesses]